{
  "symbol": "SYRE",
  "company": "Spyre Therapeutics, Inc.",
  "generated_at": "2026-06-24T07:36:53.170Z",
  "event_count": 1,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-04T05:54:07.601Z",
      "summary": "Spyre Therapeutics is a clinical-stage biotech that has generated exceptional price appreciation (+370% YTD to ~$74) on positive Phase 2 UC data (SPY001 SKYLINE trial, April 2026) and concurrent $463M equity raise. The investigation trigger was met — 3+ Form 4s in 14 days — but ALL recent transactions are pre-arranged 10b5-1 SELLs or board option grants, not open-market purchases. Zero genuine insider buy signals exist among recent filings. The company has six Phase 2 readouts expected across Q3-Q4 2026 (SKYLINE UC and SKYWAY rheumatic basket), with SPY072 TL1A expansion into RA/PsA/axSpA. However, the stock is near all-time highs after massive dilution (~10M new shares in April offering) and insider selling at elevated levels. The combination of zero open-market insider buys + recent material dilution at these prices + weak options flow with no IV premium → this is not an asymmetric long setup.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 26,
      "walltime_min": 48,
      "debug_path": "dossiers/2026-06-04-SYRE.scout.debug.json"
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "SYRE",
    "call": "BUY",
    "confidence": 4,
    "score": 7,
    "factors": {
      "above_200dma": "+2",
      "above_50dma": "+1",
      "momentum_strong_up": "+2 (382.3%)",
      "rsi_overbought": "-1 (72.1)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (7d ago)",
      "near_52w_high": "+1 (-3.3% from high)"
    },
    "summary": "BUY (score +7) · 12-1 mom 382.3% · RSI 72.1 · above_both · -3.3% from high",
    "last_close": 97.05,
    "one_month_ago_close": 74.32,
    "twelve_month_ago_close": 15.41,
    "twelve_one_momentum_pct": 382.28,
    "rsi_14": 72.1,
    "ma_stack": "above_both",
    "from_period_high_pct": -3.26,
    "period_high": 100.32,
    "price_targets": {
      "bear": 41.71,
      "fair": 90.71,
      "bull": 135,
      "bear_return_pct": -57,
      "fair_return_pct": -6.5,
      "bull_return_pct": 39.1,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 78,
        "target_mean": 100.46667,
        "target_high": 135,
        "analyst_count": 15
      }
    },
    "generated_at": "2026-06-24T07:36:53.165Z"
  }
}